BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18550858)

  • 1. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
    Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
    Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.
    Lidonnici MR; Audia A; Soliera AR; Prisco M; Ferrari-Amorotti G; Waldron T; Donato N; Zhang Y; Martinez RV; Holyoake TL; Calabretta B
    Cancer Res; 2010 Oct; 70(20):7949-59. PubMed ID: 20924107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
    Chang JS; Santhanam R; Trotta R; Neviani P; Eiring AM; Briercheck E; Ronchetti M; Roy DC; Calabretta B; Caligiuri MA; Perrotti D
    Blood; 2007 Aug; 110(3):994-1003. PubMed ID: 17475908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
    Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.
    Ferrari-Amorotti G; Keeshan K; Zattoni M; Guerzoni C; Iotti G; Cattelani S; Donato NJ; Calabretta B
    Blood; 2006 Aug; 108(4):1353-62. PubMed ID: 16670262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
    Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of C/EBPalpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation.
    Tavor S; Park DJ; Gery S; Vuong PT; Gombart AF; Koeffler HP
    J Biol Chem; 2003 Dec; 278(52):52651-9. PubMed ID: 14517214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance to paclitaxel-induced apoptosis.
    Ray S; Lu Y; Kaufmann SH; Gustafson WC; Karp JE; Boldogh I; Fields AP; Brasier AR
    J Biol Chem; 2004 Aug; 279(34):35604-15. PubMed ID: 15155749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.
    Lidonnici MR; Corradini F; Waldron T; Bender TP; Calabretta B
    Blood; 2008 May; 111(9):4771-9. PubMed ID: 18227349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-expressing cells: differences and similarities.
    Guerzoni C; Ferrari-Amorotti G; Bardini M; Mariani SA; Calabretta B
    Cell Cycle; 2006 Jun; 5(12):1254-7. PubMed ID: 16760662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CCAAT Enhancer-Binding Protein α Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway.
    Zhang G; Dong F; Luan C; Zhang X; Shao H; Liu J; Sun C
    Acta Haematol; 2016; 136(2):65-70. PubMed ID: 27161125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
    Fragliasso V; Chiodo Y; Ferrari-Amorotti G; Soliera AR; Manzotti G; Cattelani S; Candini O; Grisendi G; Vergalli J; Mariani SA; Guerzoni C; Calabretta B
    J Cell Biochem; 2012 May; 113(5):1704-13. PubMed ID: 22212957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
    Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
    J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
    Zhu XS; Lin ZY; Du J; Cao GX; Liu G
    Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of 293pT2-P210 cell line enables expression of bcr/abl to be regulated by Tet-off inducing-expression-system].
    Huang WR; Lu ZZ; Wang LS; Wang H; Duan HF; Li QF; Gao CJ; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):224-8. PubMed ID: 17493320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1.
    Soliera AR; Mariani SA; Audia A; Lidonnici MR; Addya S; Ferrari-Amorotti G; Cattelani S; Manzotti G; Fragliasso V; Peterson L; Perini G; Holyoake TL; Calabretta B
    Leukemia; 2012 Jul; 26(7):1555-63. PubMed ID: 22285998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and role of the transcription factor C/EBPα in chronic myeloid leukemia].
    Zhang G; Dong F; Luan C; Zhang X; Shao H; Liu J; Sun C
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):947-50. PubMed ID: 26632469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
    Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
    Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.